These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38326312)

  • 1. Regulating protein corona on nanovesicles by glycosylated polyhydroxy polymer modification for efficient drug delivery.
    Miao Y; Li L; Wang Y; Wang J; Zhou Y; Guo L; Zhao Y; Nie D; Zhang Y; Zhang X; Gan Y
    Nat Commun; 2024 Feb; 15(1):1159. PubMed ID: 38326312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.
    Kang B; Okwieka P; Schöttler S; Winzen S; Langhanki J; Mohr K; Opatz T; Mailänder V; Landfester K; Wurm FR
    Angew Chem Int Ed Engl; 2015 Jun; 54(25):7436-40. PubMed ID: 25940402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface roughness influences the protein corona formation of glycosylated nanoparticles and alter their cellular uptake.
    Piloni A; Wong CK; Chen F; Lord M; Walther A; Stenzel MH
    Nanoscale; 2019 Dec; 11(48):23259-23267. PubMed ID: 31782458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-targeted drug delivery by manipulating protein corona functions.
    Zhang Z; Guan J; Jiang Z; Yang Y; Liu J; Hua W; Mao Y; Li C; Lu W; Qian J; Zhan C
    Nat Commun; 2019 Aug; 10(1):3561. PubMed ID: 31395892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein corona on brain targeted nanocarriers: Challenges and prospects.
    Jiang K; Yu Y; Qiu W; Tian K; Guo Z; Qian J; Lu H; Zhan C
    Adv Drug Deliv Rev; 2023 Nov; 202():115114. PubMed ID: 37827336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer-tethered glycosylated gold nanoparticles recruit sialylated glycoproteins into their protein corona, leading to off-target lectin binding.
    Ahmad A; Georgiou PG; Pancaro A; Hasan M; Nelissen I; Gibson MI
    Nanoscale; 2022 Sep; 14(36):13261-13273. PubMed ID: 36053227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    AAPS J; 2020 Jun; 22(4):83. PubMed ID: 32495039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein deglycosylation can drastically affect the cellular uptake.
    Ghazaryan A; Landfester K; Mailänder V
    Nanoscale; 2019 Jun; 11(22):10727-10737. PubMed ID: 31120044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
    Moraru C; Mincea M; Menghiu G; Ostafe V
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein corona, influence on drug delivery system and its improvement strategy: A review.
    Guo F; Luo S; Wang L; Wang M; Wu F; Wang Y; Jiao Y; Du Y; Yang Q; Yang X; Yang G
    Int J Biol Macromol; 2024 Jan; 256(Pt 2):128513. PubMed ID: 38040159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles.
    Hadjidemetriou M; Al-Ahmady Z; Kostarelos K
    Nanoscale; 2016 Apr; 8(13):6948-57. PubMed ID: 26961355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of the protein corona: How washing shapes the proteome and influences cellular uptake of nanocarriers.
    Brückner M; Simon J; Jiang S; Landfester K; Mailänder V
    Acta Biomater; 2020 Sep; 114():333-342. PubMed ID: 32726673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions.
    Wan S; Kelly PM; Mahon E; Stöckmann H; Rudd PM; Caruso F; Dawson KA; Yan Y; Monopoli MP
    ACS Nano; 2015 Feb; 9(2):2157-66. PubMed ID: 25599105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles Penetrate into the Multicellular Spheroid-on-Chip: Effect of Surface Charge, Protein Corona, and Exterior Flow.
    Huang K; Boerhan R; Liu C; Jiang G
    Mol Pharm; 2017 Dec; 14(12):4618-4627. PubMed ID: 29096441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo.
    Zhang ZA; Xin X; Liu C; Liu YH; Duan HX; Qi LL; Zhang YY; Zhao HM; Chen LQ; Jin MJ; Gao ZG; Huang W
    J Nanobiotechnology; 2021 Dec; 19(1):453. PubMed ID: 34963449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphonylation Controls the Protein Corona of Multifunctional Polyglycerol-Modified Nanocarriers.
    Danner AK; Schöttler S; Alexandrino E; Hammer S; Landfester K; Mailänder V; Morsbach S; Frey H; Wurm FR
    Macromol Biosci; 2019 May; 19(5):e1800468. PubMed ID: 30913379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Corona Formation Impacts Nanomaterials as Drug Carriers.
    Gupta MN; Roy I
    Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona.
    Weber C; Voigt M; Simon J; Danner AK; Frey H; Mailänder V; Helm M; Morsbach S; Landfester K
    Biomacromolecules; 2019 Aug; 20(8):2989-2999. PubMed ID: 31268685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system.
    Xiao W; Gao H
    Int J Pharm; 2018 Dec; 552(1-2):328-339. PubMed ID: 30308270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the protein corona in chitosan-based nanoparticles.
    Caprifico AE; Foot PJS; Polycarpou E; Calabrese G
    Drug Discov Today; 2021 Aug; 26(8):1825-1840. PubMed ID: 33892141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.